Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Clinton's drug price cap will hit R&D spend and CRO revenues say experts

A proposed prescription drug price cap will lead to reductions in R&D spending and could have a negative knock-on effect for CROs say experts.

Recipharm to cut jobs in Sweden to reduce costs

Recipharm will cut jobs to reduce costs after lower customer demand.

UK private equity group buys Doppel Farmaceutici citing EU CDMO market potential

Trilantic Capital Partners Europe has bought a majority stake in Doppel Farmaceutici, citing the growth potential of Europe’s contracting market as the driver.

AmerisourceBergen takeover target Pharmedium pulls drugs made with Hospira saline

US compounder Pharmedium has recalled sterile drugs made with contaminated saline supplied by Pfizer's Hospira unit.

US FDA issues alert for sterile products made by Californian compounder

The US FDA has issued a product safety alert and recommended a compounding pharmacy cease manufacturing operations after observing unsanitary conditions at a Californian facility.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...